Cargando…

ISTH interim guidance on recognition and management of coagulopathy in COVID‐19: A comment

Detalles Bibliográficos
Autores principales:	Barrett, Christopher D., Moore, Hunter B., Yaffe, Michael B., Moore, Ernest E.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	International Society on Thrombosis and Haemostasis. Published by Elsevier Inc. 2020
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9770921/ https://www.ncbi.nlm.nih.gov/pubmed/32302462 http://dx.doi.org/10.1111/jth.14860

Ejemplares similares

RE: ISTH interim guidance to recognition and management of coagulopathy in COVID‐19
por: Akima, Satoshi, et al.
Publicado: (2020)

ISTH interim guidance on recognition and management of coagulopathy in COVID‐19
por: Thachil, Jecko, et al.
Publicado: (2020)

“ISTH guidelines for antithrombotic treatment in COVID‐19”: Comment from Huisman et al.
por: Huisman, Menno V., et al.
Publicado: (2022)

“ISTH guidelines for antithrombotic treatment in COVID‐19”: Reply
por: Schulman, Sam, et al.
Publicado: (2022)

COVID‐19 associated coagulopathy and thromboembolic disease: Commentary on an interim expert guidance
por: Cannegieter, Suzanne C., et al.
Publicado: (2020)

Management of cancer‐associated thrombosis with thrombocytopenia: Impact of the ISTH guidance statement
por: Held, Nicole, et al.
Publicado: (2022)

Assessment of Patients with von Willebrand Disease with ISTH/BAT and PBQ Scores
por: Belen Apak, Fatma Burcu, et al.
Publicado: (2020)

Proteomics of Coagulopathy Following Injury Reveals Limitations of Using Laboratory Assessment to Define Trauma-Induced Coagulopathy to Predict Massive Transfusion
por: Moore, Hunter B., et al.
Publicado: (2022)

COVID-19, coagulopathy and venous thromboembolism: more questions than answers—comment
por: Ponzetto, Antonio, et al.
Publicado: (2020)

ISTH Abstract
Publicado: (2022)

Curcumin and Coagulopathy in the COVID19 Era
por: Suresh, Padmanaban S.
Publicado: (2020)

Comment on Kanis et al.: “European guidance for the diagnosis and management of osteoporosis in postmenopausal women”
por: Clausen, J. O.
Publicado: (2008)

Antithrombotic Treatment in Patients With Hemophilia: an EHA-ISTH-EAHAD-ESO Clinical Practice Guidance
por: Schutgens, Roger E.G., et al.
Publicado: (2023)

Comments on “Whole lung irradiation as a novel treatment for COVID-19: Interim results of an ongoing phase 2 trial in India”
por: Ghaznavi, Hamid, et al.
Publicado: (2022)

Dermatologists’ Role in the Diagnosis and Management of Coronavirus Disease 2019 Coagulopathy
por: Shah, Payal, et al.
Publicado: (2020)

Covid-19-induced coagulopathy and observed benefits with anticoagulation
por: Karimzadeh, Sedighe, et al.
Publicado: (2020)

Response to comments on “Whole lung irradiation as a novel treatment for COVID-19: Interim results of an ongoing phase 2 trial in India”
por: Ganesan, Govindaraj, et al.
Publicado: (2022)

ISTH 2017 Berlin revisited
por: Ruf, Wolfram
Publicado: (2017)

Evidence is Lacking for the NHS England Interim Guidance for Managing Metastatic Non-small Cell Lung Cancer in the COVID-19 Pandemic
por: Choudhury, M., et al.
Publicado: (2021)

Global haemostatic tests in rapid diagnosis and management of COVID-19 associated coagulopathy in acute limb ischaemia
por: Fan, Bingwen Eugene, et al.
Publicado: (2020)

Comments on splanchnic nerve neurolysis via the transdiscal approach under fluoroscopic guidance: a retrospective study
por: Silva-Ortiz, Victor M., et al.
Publicado: (2022)

COVID-19 associated coagulopathy: The crowning glory of thrombo-inflammation concept
por: Gris, Jean-Christophe, et al.
Publicado: (2020)

Coagulopathy profiles and their correlation with molecular viral burden in patients with COVID-19
por: Park, Hee Sue, et al.
Publicado: (2021)

Completing 'Interim Discharge Letter'
por: Clements, David, et al.
Publicado: (1992)

Is there a role for tissue plasminogen activator as a novel treatment for refractory COVID-19 associated acute respiratory distress syndrome?
por: Moore, Hunter B., et al.
Publicado: (2020)

Illustrated State‐of‐the‐Art Capsules of the ISTH 2022 Congress
por: Ariëns, Robert A., et al.
Publicado: (2022)

Comments on: Preferred practice guidelines for glaucoma management during COVID-19 pandemic
por: Parikh, Rajul S, et al.
Publicado: (2020)

Circulating histones play a central role in COVID-19-associated coagulopathy and mortality
por: Shaw, Rebecca J., et al.
Publicado: (2021)

Salvage use of tissue plasminogen activator (tPA) in the setting of acute respiratory distress syndrome (ARDS) due to COVID-19 in the USA: a Markov decision analysis
por: Choudhury, Rashikh, et al.
Publicado: (2020)

Illustrated State‐of‐the‐Art Capsules of the ISTH 2020 Congress
por: Ariens, Robert, et al.
Publicado: (2020)

Illustrated State‐of‐the‐Art Capsules of the ISTH 2020 Congress
por: Krishnaswamy, Sriram, et al.
Publicado: (2021)

Illustrated State-of-the-Art Capsules of the ISTH 2023 Congress
por: Kahn, Susan R., et al.
Publicado: (2023)

Interim Guidance for Urodynamic Practice during COVID-19 Pandemic
por: Figueiredo, André Avarese, et al.
Publicado: (2020)

Illustrated State‐of‐the‐Art Capsules of the ISTH 2019 Congress in Melbourne, Australia
por: Ward, Christopher M., et al.
Publicado: (2019)

Serial “death diamond” TEGs are a bedside indicator of futile resuscitation during massive transfusion
por: Moore, Ernest E., et al.
Publicado: (2023)

Comment on ‘Management of Cardiac Sarcoidosis in 2020’
por: Korovesis, Socrates, et al.
Publicado: (2021)

Comment on: update on the management of overactive bladder
por: Staskin, David
Publicado: (2022)

Use of nasopharyngeal airway for interim dilatation of lower tracheal stenosis
por: Anand, Lakesh Kumar, et al.
Publicado: (2011)

Coagulopathy monitoring and anticoagulation management in COVID-19 patients on ECMO: Advantages of a heparin anti-Xa-based titration strategy
por: Rhoades, Ruben, et al.
Publicado: (2021)

Guidance on interim analysis methods in clinical trials
por: Ciolino, Jody D., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_cj1igm4449oe7rlk9m7a24lv0c